Clicky

PolTREG S.A.(PTG)

Description: Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.


Keywords: Medicine Biotechnology Clinical Medicine Diabetes Autoimmune Disease Multiple Sclerosis Autoimmunity Type 1 Diabetes Therapies For Autoimmune Diseases Tolerogenic Therapy

Home Page: poltreg.tech

Waly Piastowskie 1 lok. 1508
Gdansk, 80-855
Poland
Phone: 48 512 53 24 01


Officers

Name Title
Mr. Piotr Trzonkowsk Pres of the Management Board
Ms. Kamilla Agnieszka Bok Member of the Management Board & Director of Operations
Mr. Mariusz Jablonski Member of the Management Board

Exchange: WAR

Country: PL : Poland

Currency: Polish złoty (zł)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.0856
Price-to-Sales TTM: 178.9147
IPO Date:
Fiscal Year End: December
Full Time Employees: 11
Back to stocks